DIA-US FDA-EMA-MHRA-CDSCO Clinical Trials Workshop - Regulatory Expectations and Data Quality in the time of COVID-19 and Beyond

US FDA Generic Drug Application Overview During COVID-19

Malik Imam

Office of Generic Drugs (OGD), US Food And Drug Administration (USFDA), United States

Deputy Director of the Office of Regulatory Operations (ORO)